Clariane SE provides care homes, healthcare facilities and services, and shared living solutions in France, Germany, Benelux, Italy, Spain, and the United Kingdom. It operates long-term care and short stay nursing homes. The company also provides inpatient and outpatient services, full-time hospitalization, day hospitalization, and outpatient care, and operates post-acute and rehabilitation care clinics, mental healthcare clinics, and medicine-surgery-obstetrics facilities. In addition, it offers medicalized nursing homes and alternative living solutions, such as shared houses, assisted living, and domiciliary care, as well as outpatient consultations and diagnostics, and social care services. The company was formerly known as Korian and changed its name to Clariane SE in June 2023. Clariane SE was founded in 2001 and is headquartered in Paris, France.
Frequently asked questions
What sector does Korian (KO2) operate in?
Korian belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is Korian (KO2) current stock price?
As of the latest data, Korian stock price is €3.08, with a previous close of €3.17. Korian lost -€0.09 in the last trading session, representing a -2.84% loss.
What is Korian (KO2) current market capitalization?
Korian market cap is approximately 1.10 billion.
What is Korian (KO2) Earnings Per Share (EPS)?
The trailing EPS is €0.03.
What is Korian (KO2) Price-to-Earnings (P/E) ratio?
Korian current P/E ratio is 102.53.
Does Korian (KO2) pay dividends?
No. Korian does not pay a dividend.
When is Korian (KO2) next earnings report?
Korian is expected to release its next earnings report on December 31, 2026.
What is Korian (KO2) beta (volatility) score?
Korian has a beta of 0.813, meaning its volatility is roughly in line with the market.